Not too late to short MRK and SGP

Article Submitted by: pharmaking
Stocks - Options - Mutual Funds


Tags: Pfe, Mrk, Sgp, Azn, Vytorin, Zetia.

While Merck and Schering Plough have already fallen hard, they should both continue to fall for the forseeable future

 

Submitted: Jan 27, 2008    Views: 292    Comments: 0    Likes: 2   


As I predicted the sales of vytorin and zetia would fall off a cliff after the release of the ENHANCE trial showing no additional benefit of adding ezetimibe to simvastatin.   I suggested taking a short  position in MRK and SGP the day after the news came out. I hope some people followed my advice- the trade has been very good to me so far- making 20% in 10 market days. So what should we do now. Take the money off the table, let it ride or double down. Certainly the easy money has been made. Still, I suspect that the MRK and SGP will continue to grind down. 

Here are my reasons:

1-      The trial showed no clear evidence of harm for using ezetimibe. As a result, we are generally not calling all patients on the drug to stop it. In general, we are waiting until we see the patient, or patients call to make the switch. So scripts will fall fast at first ( driven mainly by patient requests) and then slowly for a period of months- with each week being a little worse than the week before

2-      IMS numbers which are released tomorrow. They will be very bad. My guess is for a 65% fall in new Rxs.

3-      The ACC meeting in March- when the data will be officially presented- will provide another leg down in terms of sentiment.

4-      In addition to all of this, Merck will be stopping their successful advertising related to vytorin and zetia. Look for PFE and AZN to ramp up their ad-spend on Lipitor and Crestor.

5-      While I don’t see much rational behind the lawsuits that are starting to build- I would expect that these suits will cost MRK and SGP a lot of money. Merck’s vioxx strategy of defending all cases to the death seems to work, but lawyers don’t come cheap.

    SGP took a “Cramer bounce” after hours on Friday. I plan to take advantage of it and short the stock in the premarket on Monday. 




Related Articles:



2

Email this story Email to someone | Print Story Print Content | Add to reading list



Add Your Comments:

Your Name:

Spam protection control:


© Copyright 2008 pharmaking All rights reserved. pharmaking has granted BestCashCow.com, LLC non-exclusive rights to display this work on Bestcashcow.com.

Financial products of all nature bear inherent risks and this website is not a financial advisory service; it is a forum for users to share and to compare notes and observations on financial publications. The website provides, free of charge, the technical and logistical apparatus and the medium for users to share and to publish financial information and to comment on publications. As such, the website’s operator can not and does not take responsibility for information, observations or opinions of any sort or nature provided by third parties with whom it is not affiliated who use the website to publish, to comment or as a means of solicitation. Users are specifically warned against following any advice related to specific instruments, including, but not limited to, equity securities, that may be provided by other users directly on this site or on web pages to which other users have provided links on this site. BestCashCow.com can not and does not check or verify the qualifications and credentials of users who publish or comment on this site or on linked pages. Users should seek personalized advice from qualified professionals regarding all personal financial issues and evaluate the risks and applicability to their own circumstances of each financial product discussed regardless of who the publisher is or purports to be. Should you, through your use of this site, identify an individual or organization purporting to offer personalized advice, you bear all responsibility to ensure that the individual or organization has the qualifications that they may represent on the website, and that their advice is appropriate for your circumstances. On certain webpages, BestCashCow.com provides information related to rates on US-based savings accounts, CDs, short-term government bonds, and other US cash equivalent securities, also free of charge to internet users for their independent use. The accuracy of this information is not guaranteed, and the information, like all other information on this website, should not be construed to provide investment advice, nor to endorse a financial product of any sort.

© 2007 BestCashCow.com, LLC. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy.